We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+31.89%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
-$18.2M
(-0.99%)
Cap. Flow
-$444M
Cap. Flow
% of AUM
-24.46%
Top 10 Holdings %
Top 10 Hldgs %
40.04%
Holding
396
New
38
Increased
53
Reduced
183
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$24.1M |
| 2 |
Parker-Hannifin
PH
|
+$20.9M |
| 3 |
Ameriprise Financial
AMP
|
+$15.8M |
| 4 |
THS
Treehouse Foods
THS
|
+$12.2M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$48.5M |
| 2 |
Microsoft
MSFT
|
+$45.5M |
| 3 |
Biogen
BIIB
|
+$36M |
| 4 |
Amazon
AMZN
|
+$29.7M |
| 5 |
Burlington
BURL
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.49% |
| 2 | Healthcare | 16.85% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Communication Services | 8.43% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Evertec
EVTC
$1.77B
| $1.01M | 0.06% |
35,895
-267
| -0.7% | -$7.08K |
|
102
Progress Software
PRGS
$1.78B
| $979K | 0.05% |
25,262
-173
| -0.7% | -$6.59K |
|
103
Encompass Health
EHC
$12.5B
| $970K | 0.05% |
19,691
-153
| -0.8% | -$8.26K |
|
104
Boise Cascade
BCC
$2.96B
| $968K | 0.05% |
25,742
-180
| -0.7% | -$5.64K |
|
105
InterDigital
IDCC
$8.99B
| $954K | 0.05% |
+16,849
| New | +$896K |
|
106
Supernus Pharmaceuticals
SUPN
$2.74B
| $898K | 0.05% |
+37,808
| New | +$835K |
|
107
La-Z-Boy
LZB
$1.66B
| $846K | 0.05% |
31,249
-202
| -0.6% | -$4.86K |
|
108
Amneal Pharmaceuticals
AMRX
$5.71B
| $827K | 0.05% |
+173,820
| New | +$716K |
|
109
Maximus
MMS
$2.9B
| $817K | 0.05% |
11,591
-80
| -0.7% | -$5.38K |
|
110
Innospec
IOSP
$2.29B
| $799K | 0.04% |
10,338
-71
| -0.7% | -$5.19K |
|
111
Generac Holdings
GNRC
$12.2B
| $776K | 0.04% |
6,364
-22
| -0.3% | -$2.32K |
|
112
Pacira BioSciences
PCRX
$974M
| $751K | 0.04% |
14,322
-49
| -0.3% | -$2.05K |
|
113
Boston Beer
SAM
$1.86B
| $751K | 0.04% |
1,400
-354
| -20% | -$171K |
|
114
MasTec
MTZ
$21.5B
| $695K | 0.04% |
15,481
-122
| -0.8% | -$4.62K |
|
|
AMWD
115
DELISTED
American Woodmark
AMWD
| $686K | 0.04% |
9,070
-78
| -0.9% | -$4.46K |
|
|
CATM
116
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $678K | 0.04% |
28,267
-226
| -0.8% | -$5.06K |
|
|
CSOD
117
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $647K | 0.04% |
16,768
-100
| -0.6% | -$3.52K |
|
118
RH
RH
$3.47B
| $645K | 0.04% |
2,590
-30
| -1% | -$5.43K |
|
119
Molina Healthcare
MOH
$10.4B
| $644K | 0.04% |
3,620
-30
| -0.8% | -$5.11K |
|
120
Dr. Reddy's Laboratories
RDY
$10.1B
| $644K | 0.04% |
60,750
-10,650
| -15% | -$108K |
|
121
FormFactor
FORM
$8.79B
| $643K | 0.04% |
+21,938
| New | +$541K |
|
122
Strategic Education
STRA
$1.84B
| $637K | 0.04% |
4,144
-15
| -0.4% | -$2.34K |
|
123
Brinker International
EAT
$9.76B
| $625K | 0.03% |
26,036
-210
| -0.8% | -$4.51K |
|
|
EFOR
124
Everforth Inc
EFOR
$1.33B
| $573K | 0.03% |
+8,591
| New | +$456K |
|
125
PetMed Express
PETS
$42.1M
| $572K | 0.03% |
16,054
-7,100
| -31% | -$247K |
|
Similar funds
M
GWM
QT
SCM
TW
KFA
SG
FFA
Smith Group Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Smith Group Asset Management held 396 positions worth $1.81B, down 0.99% from $1.83B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Smith Group Asset Management withdrew a net $444M in Q2 2020, closing 98 positions and reducing 183 holdings. Its most notable exit was Biogen, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Smith Group Asset Management opened a new position in Hologic worth $28M.
- Smith Group Asset Management's largest Q2 2020 buy was Hologic: 490,762 shares worth $28M.
- Smith Group Asset Management added most to Ameriprise Financial in Q2 2020, an estimated $15.8M increase.
- Smith Group Asset Management's biggest Q2 2020 reduction was Apple, cutting an estimated $48.5M.
- Smith Group Asset Management fully exited Biogen in Q2 2020, selling an estimated $36M.
- Smith Group Asset Management's ten largest holdings make up 40% of its $1.81B portfolio in Q2 2020.
- Smith Group Asset Management opened 38 new positions and closed 98 in Q2 2020.
- Smith Group Asset Management's portfolio value fell 0.99% quarter-over-quarter to $1.81B.
Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.